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Abstract
Background: The second to fourth digit ratio (2D:4D) is used as a marker of prenatal sex hormone exposure. The
objective of this study was to examine whether circulating concentrations of sex hormones and SHBG measured in
adulthood was associated with 2D:4D.
Methods: This analysis was based on a random sample from the Melbourne Collaborative Cohort Study. The
sample consisted of of 1036 men and 620 post-menopausal women aged between 39 and 70 at the time of
blood draw. Concentrations of circulating sex hormones were measured from plasma collected at baseline (1990-
1994), while digit length was measured from hand photocopies taken during a recent follow-up (2003-2009). The
outcome measures were circulating concentrations of testosterone, oestradiol, dehydroepiandrosterone sulphate,
androstenedione, Sex Hormone Binding Globulin, androstenediol glucoronide for men only and oestrone sulphate
for women only. Free testosterone and oestradiol were estimated using standard formulae derived empirically.
Predicted geometric mean hormone concentrations (for tertiles of 2D:4D) and conditional correlation coefficients
(for continuous 2D:4D) were obtained using mixed effects linear regression models.
Results: No strong associations were observed between 2D:4D measures and circulating concentrations of
hormones for men or women. For males, right 2D:4D was weakly inversely associated with circulating testosterone
(predicted geometric mean testosterone was 15.9 and 15.0 nmol/L for the lowest and highest tertiles of male right
2D:4D respectively (P-trend = 0.04). There was a similar weak association between male right 2D:4D and the ratio of
testosterone to oestradiol. These associations were not evident in analyses of continuous 2D:4D.
Conclusions: There were no strong associations between any adult circulating concentration of sex hormone or
SHGB and 2D:4D. These results contribute to the growing body of evidence indicating that 2D:4D is unrelated to
adult sex hormone concentrations.
Background
The length of the index finger divided by the length of
the ring finger (2D:4D) has been proposed as a marker
of prenatal androgen action. The investigation of digit
ratios as possible markers of androgen action in early
life began with the long-recognised observation that,
compared with women, adult males tend to have longer
ring fingers relative to other fingers. Contemporary
anthropological studies have found small but consistent
sex differences in 2D:4D, with men having lower average
2D:4D than women [1-3]. The ratio 2D:4D varies sub-
stantially by ethnicity, with more variability in 2D:4D
accounted for by ethnic differences than sex differences
[4]. However, the magnitude of sex differences in 2D:4D
is similar across ethnic groups [4].
Studies have investigated possible associations between
2D:4D and a broad range of outcomes, including sexual
orientation [5-11], sporting ability and physical fitness
[12-18], and language development [19]. Sex hormone
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exposure in early life has also been implicated in the
etiology of numerous diseases, including cancer [20].
There are several lines of evidence indicating that pre-
natal sex hormone exposure is associated with 2D:4D
[2]. For instance the development of genitals and digits
is controlled by the HoxA and HoxD genes [21]. Also,
the sex difference in 2D:4D is observable at the end of
the first trimester of fetal development [22]. Right hand
2D:4D measured at 2 years of age was found to be nega-
tively correlated with the ratio of testosterone to oestra-
diol measured by amniocentesis in the second trimester
[23], however this association was only observed for
both sexes combined as the study was underpowered to
detect within sex associations, and no strong association
was observed between right 2D:4D and testosterone
itself.
Perhaps the strongest evidence of the association
between androgens and digit ratio comes from a consid-
eration of links between 2D:4D and both the amount of
testosterone before birth and an individual’s sensitivity
to testosterone. With regard to the former, children
with congenital adrenal hyperplasia (CAH: a condition
in which prenatal androgen levels are very high) have
been shown to have lower mean 2D:4D than controls
[3]. With regard to the latter, the CAG polymorphism
in the androgen receptor influences sensitivity to andro-
gens such that low CAGn is linked to high sensitivity.
There is some evidence that low 2D:4D is associated
with low CAGn [24], however a recent study has failed
to replicate these findings [25]. Nevertheless, a strong
link between 2D:4D and sensitivity to testosterone has
been indicated by the recent finding that testosterone
administration lowers cognitive empathy in women, but
this effect is modified by 2D:4D such that participants
with low 2D:4D show the greatest reduction in empathy
[26]. There is both cross sectional [1] and longitudinal
[27,28] evidence that sex differences in 2D:4D are unaf-
fected by puberty, suggesting that 2D:4D is established
very early in life. This makes 2D:4D an excellent candi-
date biomarker for examining putative associations
between prenatal sex hormone exposure and risk of var-
ious sex hormone related conditions throughout the
lifespan.
Typically any association between 2D:4D and an out-
come Y is interpreted as a direct association between
prenatal sex hormone exposure and Y. However this
interpretation will be invalid if 2D:4D is also associated
with adult hormone concentrations. In this case any
association between 2D:4D and Y will not uniquely indi-
cate an association with prenatal sex hormone exposure,
but may also reflect an association between adult hor-
mone concentrations and the outcome of interest.
While the longitudinal stability of sex differences in
2D:4D suggests that a causal effect of adult hormone
concentrations on 2D:4D can be excluded [27,28], it is
widely assumed that prenatal and adult hormone con-
centrations are correlated. Consistent with this assump-
tion, prenatal testosterone appears to stem from the
fetus rather than the mother, as evidenced by the lack
of association between concentrations of amniotic tes-
tosterone and maternal serum testosterone [29]. There-
fore, since prenatal and adult sex hormones may stem
from the same organs, their concentrations might be
correlated. If there is a substantial correlation between
prenatal and adult hormone concentrations we would
expect to observe a correlation between 2D:4D measures
and adult hormone concentrations.
Several studies to date have investigated possible asso-
ciations between concentrations of adult sex hormones
and 2D:4D, as well as the difference between right and
left 2D:4D (Δr-l) [1,5,30-37]. Each of these 10 studies,
plus data from two new samples was included in a
meta-analytic review of adult sex hormone concentra-
tions and 2D:4D [38]. This meta-analysis of 332 women
and 850 men aggregated correlations between adult hor-
mone concentrations (measured from either serum or
saliva) and 2D:4D, and overall found no association
between 2D:4D and adult sex hormone concentrations,
except in analyses that included a clinical sample of
men attending a fertility clinic. We aim to examine
whether 2D:4D or Δr-l was associated with circulating
hormone concentrations measured in a large, ethnically
diverse sample of men and post-menopausal women
participating in the Melbourne Collaborative Cohort
Study (MCCS).
Methods
Study sample
The MCCS is a prospective cohort study of 41,514 peo-
ple (17,045 men and 24,469 women) who were aged
between 27 and 81 years at baseline (99.3% of whom
were aged 40-69). Recruitment occurred between 1990
and 1994 in the Melbourne metropolitan area. Partici-
pants were recruited via the Electoral Rolls (enrollment
to vote is compulsory for adults in Australia). Italian
and Greek immigrants were deliberately over-sampled in
order to include a broader range of diets and lifestyles in
the study. There are 5,411 Italian and 4,525 Greek born
participants, making up approximately 24% of the study
sample. At baseline, participants were interviewed about
their personal medical history and family history of dis-
ease, smoking and alcohol consumption, physical activ-
ity, and other social and lifestyle factors. A full
reproductive history was sought from women, and all
participants completed a food frequency questionnaire
specifically developed for the MCCS. Physical measure-
ments were also taken, and each participant provided a
blood sample. Full details of the MCCS baseline phase
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are published elsewhere [39]. All participants provided
written informed consent, and the study was approved
by the Ethical Review Board at the Cancer Council
Victoria.
Eligibility for the present study was restricted to a
sample of 4659 MCCS participants (2167 men and 2492
women) who were selected for studies of plasma hor-
mone concentrations and cancer [40,41]. The sample
was chosen randomly from participants who had not
been diagnosed with prostate, colorectal, breast or ovar-
ian cancer prior to baseline and, for women only, were
not using hormone replacement therapy (HRT) at
baseline.
Measurement of 2D:4D
During a face-to-face follow-up conducted during 2003-
2009, participants had their hands photocopied for the
purpose of measuring 2D:4D ratios. The length of the
second (index) and fourth (ring) fingers were measured
from photocopies of the surface of the hand using ver-
nier calipers with a resolution of 0.01mm. Measure-
ments were taken from the tip of the finger to the basal
crease. Where two creases were visible at the base of
the digit, the crease proximal to the palm was chosen.
The length of the index finger was divided by the length
of the ring finger to obtain 2D:4D, and Δr-l was calcu-
lated as the difference between right and left 2D:4D.
The measurement was undertaken by a team of trained
research assistants at the Cancer Council Victoria.
Measurement of circulating hormones
The methods used to measure circulating concentra-
tions of sex hormone concentrations are described in
detail in Baglietto et al. and Severi et al. [40,41].
Plasma samples were retrieved from liquid nitrogen,
aliquoted into 450 μL volumes, and shipped on dry ice
in batches of 80 samples to the laboratory where sex
hormone binding globulin (SHBG), testosterone, total
oestradiol, dehydroepiandrosterone sulphate (DHEAS),
and androstenedione were measured for all participants.
In addition, androstenediol glucoronide was measured
for men and oestrone sulphate was measured for
women. Assignment to batches was done randomly for
each sex, and one scientist did all measurements. Ten
percent of the samples in each batch were aliquots from
pooled plasma that had been stored with the samples
from participants.
Testosterone followed by total oestradiol was mea-
sured by electrochemiluminescence immunoas- say
(Elecsys 2010 analyzer, Roche Diagnostics GmbH, Man-
nheim, Germany). DHEAS was measured by competitive
immunoassay (IMMULITE analyzer, DPC, Los Angeles,
CA). Androstenedione and androstenediol glucuronide
were analysed by RIA (DSL-4200; TX). Oestrone
sulphate was measured by RIA (DSL-5400). SHBG was
measured by immunometric assay (IM- MULITE analy-
zer, DPC).
From the pooled plasma, the overall coefficients of
variation were 7% (4% within batches and 5% between
batches) for testosterone at a concentration of 4.3 nmol/
L; 10% (8% within batches and 6% between batches) for
oestradiol at a concentration of 157 pmol/L; 10% (9%
within batches and 6% between batches) for DHEAS at
a concentration of 4.0 μmol/L; 15% (11% within batches
and 9% between batches) for androstenedione at a con-
centration of 2.6 nmol/L; 15% (13% within batches and
8% between batches) for oestrone sulphate at a concen-
tration of 2.0 ng/mL; 10% (9% within batches and 5%
between batches) for androstenediol glucoronide at a
concentration of 8.0 ng/mL; and 7% (6% within batches
and 4% between batches) for SHBG at a concentration
of 45 nmol/L.
We examined the distribution of each sex hormone
for implausible values, and excluded two men from ana-
lyses of testosterone (concentration < 1 nmol/L). No
men or women had implausible values for any other
hormone.
Circulating concentrations of free testosterone were
calculated using the empirically developed formulae
reported in [42]. Concentration of free oestradiol was
calculated from the total concentration and from the
concentration of SHBG using the law of mass action
[43], under the assumption of a fixed albumin concen-
tration of 40 g/L.
Statistical analysis
One-hundred photocopies were measured by each
research assistant twice so as to assess inter-and intra-
observer reliability of the digit measurements. We fit
mixed models to the raw digit lengths and 2D:4D ratios,
with individual and research assistant entered into the
model as crossed random effects. Intra-class correlation
coefficients (ICC’s) were calculated as the proportion of
variance in digit length or digit ratio accounted for by
between individual variation.
Linear regression was used to estimate mean differ-
ences in 2D:4D and Δr-l by sex, and to estimate correla-
tions between 2D:4D measures and age. Analysis of sex
hormone concentrations and 2D:4D was undertaken
separately for men and women. Using mixed-effects lin-
ear regression models fitted by maximum likelihood,
natural log transformed values of sex hormone concen-
trations were regressed on sex-specific 2D:4D tertiles,
and predicted geometric means and 95% confidence
intervals (CI) were calculated for each tertile. The geo-
metric mean can be considered an approximation of the
median of untransformed hormone concentrations. The
likelihood ratio test was used to test for trend across
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tertiles of 2D:4D. The ratios of testosterone to oestradiol
and free testosterone to free oestradiol were also
regressed on 2D:4D tertiles. Correlations between log
hormone concentrations and continuous 2D:4D were
obtained by standardising the coefficients from mixed-
effects linear regression models. All models were
adjusted for ethnicity, age at blood draw, BMI, and
smoking status, and laboratory batch was entered as a
random intercept. For females the models were also
adjusted for previous oral contraceptive and HRT use,
parity, duration of lactation, and age at menarche.
All analyses were performed using Stata/SE 11.1 for
Linux 32 bit (Stata Corporation, College Station, TX).
Results
Inter- and intra-observer reliability was very high for
raw digit measurements, with ICC’s for left and right,
index and ring fingers all being greater than 0.95. ICC’s
for 2D:4D ratio were slightly lower than those for raw
digit measurements (0.80 for right and 0.73 for left
2D:4D), but still suggest that the observed variability in
digit ratio is largely due to individual differences rather
than measurement error.
There were 408 men who had insufficient plasma, or
whose results were deemed innappropriate for statistical
analysis by the laboratory. A further 723 males did not
have their hands photocopied, leaving 1036 men (48% of
2167 eligible) available for analysis. Of the 2492 eligible
women, the laboratory returned 1875 results deemed
appropriate for analysis. 714 women did not have their
hands photocopied, and a further 529 women were clas-
sified as pre-menopausal at time of blood draw, render-
ing them ineligible for analysis. An additional 12 women
who had missing values on potential confounders were
excluded, leaving 620 women (42% of those post-meno-
pausal women originally eligible) included in the present
study.
The mean age at baseline was 54 for men and 60 for
women. Seventy-nine percent of men and 80% of
women were born in Australia, New Zealand, or the
United Kingdom. The demographic, personal, and life-
style characteristics of participants as well as mean
plasma concentrations of hormones and 2D:4D are pre-
sented in Table 1 (men) and Table 2 (women).
Based on analyses of the whole random sample (n =
2575), women had higher mean 2D:4D than men for
both left and right hands. The mean differences in the
ratios were 0.014 (95% CI, 0.011 - 0.016; Cohen’s d =
0.37) for the right hand, and 0.013 (95% CI, 0.010 -
0.015; Cohen’s d = 0.35) for the left hand. The estimated
sex differences were not changed materially by adjusting
for age and ethnicity. There were no substantial sex dif-
ferences in Δr-l, though it was slightly higher for women
than men on average (mean difference of 0.001; 95% CI,
-0.002 - 0.003). Greek and Italian participants had
slightly lower 2D:4D than Anglo-Celtic participants, but
these differences were insubstantial (all mean differences
< 0.009). Greek and Italian participants also had lower
Δr-l than Anglo-Celtic participants (Tables 1 and 2).
There were small reductions in 2D:4D with increasing
age (for example, 0.009 (95% CI, 0.0007 - 0.010) reduc-
tion in right 2D:4D for each 10 year increase in age).
The unadjusted pairwise correlation between right
2D:4D and age was -0.23 (P < 0.001) for men and -0.18
(P < 0.001) for women. Similarly, for left 2D:4D the cor-
relation coefficient was -0.15 (P < 0.001) for men and
-0.14 for women (P < 0.001). Undadjusted pairwise cor-
relations between Δr-l and age were -0.09 (P = 0.002) for
men and -0.05 (P = 0.08) for women.
Tables 3 and 4 show the predicted (by mixed effects
linear regression models) geometric mean concentration
for each hormone and SHBG by tertiles of right and left
2D:4D and Δr-l for men and women respectively. There
was a modest inverse association between 2D:4D for the
right hand and plasma testosterone concentration for
men. Mean testosterone concentration was 15.9, 15.3,
and 15.0 nmol/L for tertiles I, II, and III of right 2D:4D
respectively (likelihood ratio test for trend P = 0.04).
Left 2D:4D and Δr-l were not associated with circulating
concentrations of total or free testosterone in males. We
observed extremely small positive associations between
Δr-l and both total and free testosterone concentrations
for women. Mean testosterone concentration was 0.6,
0.7, and 0.7 nmol/L (likelihood ratio test for trend P =
0.04), and mean free testosterone concentrations were
5.2, 6.9, and 6.5 pmol/L (likelihood ratio test for trend P
= 0.05) for tertiles I, II, and III of Δr-l respectively. No
other association between left or right 2D:4D or Δr-l and
any circulating hormone or SHBG was evident for men
or women.
Possible associations between the relative concentra-
tion of testosterone and oestradiol and 2D:4D ratios
were also assessed (Tables 5 and 6). The concentration
of circulating testosterone relative to oestradiol was
decreased with increasing right 2D:4D for males - men
in the lowest tertile of 2D:4D had a testosterone concen-
tration 160 times greater than their oestradiol concen-
tration (95% CI, 153 - 168), compared with men in the
highest tertile of 2D:4D who had 152 times higher circu-
lating testosterone relative to oestradiol (95% CI, 147 -
160); Ptrend = 0.03). A similar inverse association was
seen between right 2D:4D and relative concentrations of
free testosterone and free oestradiol, with men in the
lowest 2D:4D tertile having 157 times higher circulating
testosterone relative to oestradiol (95% CI 149 - 165)
and men in the highest 2D:4D tertile having 146 times
higher testosterone relative to oestradiol (95% CI 138 -
155; Ptrend = 0.02) There was no statistical evidence
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that left 2D:4D or Δr-l were associated with relative con-
centration of testosterone and oestradiol for males.
Neither right or left 2D:4D or Δr-l were associated with
relative concentrations of testosterone and oestradiol for
females.
Discussion
We found that although women had slightly higher
average 2D:4D than men, there was substantial overlap
of the distributions of 2D:4D for men and women.
There were no notable differences in 2D:4D between
participants of Anglo-Celtic, Italian, or Greek ethnic
backgrounds, though Italian and Greek participants had
slightly lower Δr-l than participants of Anglo-Celtic
descent. We found that older participants had slightly
lower 2D:4D measures than younger participants on
average. This association indicates that there may be
birth cohort effects on the underlying determinants of
2D:4D.
No hormone or SHBG examined in the present study
was strongly associated with either left or right 2D:4D
for men or women. The weak inverse associations
observed between right 2D:4D and total testosterone, as
well as testosterone relative to oestradiol for men were
all in the expected direction, with increasing 2D:4D
associated with decreasing concentrations of testoster-
one and testosterone relative to oestradiol. The weak
association between Δr-l and testosterone for women
Table 1 Demographic and lifestyle factors, and plasma concentrations of hormones and SHBG for the 1036 men
Characteristic Category Values
Age in years, mean (SD) 54 (9)
Country of birth, n (%) Australia/New Zealand/UK/Other 816 (79)
Italy 129 (12)
Greece 91 (9)
Smoking, n (%) Never 459 (44)
Current 128 (12)
Former 449 (43)
Alcohol consumption, n (%) Abstainers 126 (12)
Ex drinkers 49 (5)
Low 693 (67)
Medium 97 (9)
High 71 (7)
BMI (kg/m2), mean (SD) 26.9 (3.4)
Right 2D:4D, mean (SD) Overall 0.946 (0.036)
Australia/New Zealand/UK/Other 0.948 (0.035)
Italy 0.938 (0.041)
Greece 0.941 (0.035)
Left 2D:4D, mean (SD) Overall 0.954 (0.035)
Australia/New Zealand/UK/Other 0.955 (0.035)
Italy 0.949 (0.039)
Greece 0.955 (0.032)
Δr-l 2D:4D, mean (SD) Overall -0.008 (0.033)
Australia/New Zealand/UK/Other -0.007 (0.031)
Italy -0.011 (0.041)
Greece -0.014 (0.034)
Hormones and SHBG, geometric mean (interquartile range)1
Total testosterone (nmol/L) 15.5 (12.3,19.5)
Free testosterone (pmol/L) 244.1 (189.3,306.1)
Total oestradiol (pmol/L) 103.0 (87.0,122.0)
Free oestradiol (pmol/L) 1.7 (1.4,2.0)
DHEAS (μmol/L) 3.5 (2.3,5.2)
Androstenedione (nmol/L) 4.1 (3.2,5.4)
Androstenediol glucoronide (ng/mL) 14.8 (10.3,20.2)
SHBG (nmol/L) 35.2 (27.0,43.8)
Testosterone:oestradiol ratio 151.6 (118.5,187.3)
1At baseline blood collection. Number of missing measures were 2 for testosterone, 2 for free testosterone,and 66 for androstenediol glucoronide.
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Table 2 Demographic and lifestyle factors, and plasma concentrations of hormones and SHBG for the 620 women
Characteristic Category Values
Age in years, mean (SD) 60 (6)
Age at menopause in years, mean (SD) 50 (4)
Country of birth, n (%) Australia/New Zealand/UK/Other 496 (80)
Italy 83 (13)
Greece 41 (7)
Smoking, n (%) Never 446 (72)
Current 42 (7)
Former 132 (21)
Alcohol consumption, n (%) Abstainers 267 (43)
Ex drinkers 16 (3)
Low 268 (43)
Medium 57 (9)
High 12 (2)
Age at menarche, n (%) <12 104 (17)
12 126 (20)
13 149 (24)
>= 14 241 (39)
Parity, n (%) Nulliparous 72 (12)
<25 years and 1 pregnancy 38 (6)
<25 years and >1 pregnancy 175 (28)
>= 25 years and 1 pregnancy 169 (27)
>= 25 years and >1 pregnancy 166 (27)
Duration of lactation, n (%) never 156 (25)
<= 6 months 123 (20)
7-12 months 104 (17)
13-24 months 141 (23)
> 24 months 96 (15)
Oral Contraceptive use, n (%) Never 326 (53)
Ex 294 (47)
HRT use, n (%) Never 531 (86)
Ex 89 (14)
BMI (kg/m2), mean (SD) 27.3 (4.9)
Right 2D:4D, mean (SD) Overall 0.953 (0.035)
Australia/New Zealand/UK/Other 0.954 (0.035)
Italy 0.954 (0.034)
Greece 0.945 (0.030)
Left 2D:4D, mean (SD) Overall 0.961 (0.036)
Australia/New Zealand/UK/Other 0.961 (0.036)
Italy 0.963 (0.036)
Greece 0.962 (0.038)
Δr-l 2D:4D, mean (SD) Overall -0.008 (0.035)
Australia/New Zealand/UK/Other -0.007 (0.035)
Italy -0.010 (0.035)
Greece -0.017 (0.035)
Hormones and SHBG, geometric mean (interquartile range)1
Total testosterone (nmol/L) 0.7 (0.4,1.1)
Free testosterone (pmol/L) 7.5 (3.5,12.5)
Total oestradiol (pmol/L) 57.0 (45.0,73.0)
Free oestradiol (pmol/L) 0.8 (0.6,1.1)
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was not in the expected direction. The estimated condi-
tional correlations between 2D:4D measures and hor-
mone concentrations were all close to zero, indicating
that the detected associations are negligible.
Previous studies have suggested that the relative
length of the 2nd and 4th digit (2D:4D) is related to
prenatal sex hormones, with low 2D:4D associated with
exposure to higher concentrations of prenatal testoster-
one relative to oestradiol. This has led to the use of
2D:4D as a tool to investigate possible associations
between prenatal sex hormone exposure and various
behaviours, diseases, and disorders. If 2D:4D is also
associated with adult circulating hormone concentra-
tions then inference in such studies becomes compli-
cated, as any association between 2D:4D and an
outcome will be conflated with adult hormone concen-
trations. In this case measuring 2D:4D would have lim-
ited added value when hormone concentrations have
been measured directly.
Our results are generally consistent with those
reported previously. The only studies to date that have
reported moderate correlations between adult sex hor-
mone concentrations and 2D:4D are analyses of samples
of men attending fertility clinics [1,37]. Studies of non-
clinical samples have typically reported null results, and
a recent meta analytic review of all studies only reported
significant correlations for analyses that included sam-
ples of patients from fertility clinics [38].
The finding that there is substantial overlap in the dis-
tributions of 2D:4D for males and females has been pre-
viously reported, and it has been suggested on this basis
that 2D:4D can be rejected as a biomarker of prenatal
androgen exposure [44,45]. It is certainly true that dis-
crimination and prediction of an individual’s phenotype
(such as sex) based soley on 2D:4D is highly inaccurate.
However there remains much evidence that prenatal
androgens affect 2D:4D, and the distinction needs to be
made between the use of 2D:4D as a discriminative or
predictive tool, and 2D:4D as a (albeit imperfect) tool to
study possible associations [46].
Our study extends the results of previous studies to an
older population. The age range of participants in this
study is also wider than that in any single previous
study. Our study is by far the largest to date, with suffi-
cient power to detect very small differences in sex hor-
mone concentrations. Also, we were able to adjust our
models for numerous factors that were collected during
the baseline interview. The reproducibility of the hor-
mone and digit measurements is also a strength of our
study.
This study has some limitations. Blood samples were
collected at various times throughout the day, so circa-
dian rhythms in hormone secretion is a source of var-
iance in hormone measurements that might make
correlations difficult to detect. Also, blood samples
were collected at recruitment into the cohort, whereas
digit ratios were measured during routine follow up at
least ten years later. Not all participants attended fol-
low up, and even though it is unlikely that participants
lost to follow up differ systematically from those who
attended in terms of digit ratio, we cannot rule out the
possibility that our sample is somehow biased. This is
unlikely to be a problem for the interpretation of asso-
ciations, as there is some evidence that 2D:4D remains
stable over time [28]. Also, due to fluctuations in con-
centrations of circulating hormones throughout the
menstrual cycle, we have not been able to assess
whether 2D:4D is associated with circulating hormone
concentrations for pre-menopausal women. Another
limitation of our study is that we measured digits from
photocopies of the hand rather than directly on the
ventral surface of the hand. Photocopies have been
shown to yield lower 2D:4D values than direct mea-
surement [47]. This limitation is not critical, as our
measurement technique was identical for all our
participants.
Conclusions
No circulating hormone or SHGB was strongly asso-
ciated with 2D:4D for men or women. These results
contribute to the growing body of evidence that 2D:4D
is unrelated to circulating hormone concentrations in
adulthood. To the extent that 2D:4D reflects sensitivity
to and prenatal exposure to sex hormones, these results
suggest that associations between 2D:4D and hormone
related behaviours, diseases, and disorders can be
Table 2 Demographic and lifestyle factors, and plasma concentrations of hormones and SHBG for the 620 women
(Continued)
DHEAS (μmol/L) 1.5 (0.9,2.5)
Androstenedione (nmol/L) 2.5 (1.6,3.5)
Oestrone sulphate (ng/mL) 1.0 (0.7,1.4)
SHBG (nmol/L) 50.4 (37.7,68.3)
Testosterone:oestradiol ratio 12.5 (7.8,18.4)
1At baseline blood collection. Number of missing measures were 54 for free testosterone and 13 for oestrone sulphate.
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Table 3 Predicted geometric mean (G1) hormone concentration in men by tertiles of right and left 2D:4D and Δr-l.
Right Hand Left Hand Δr-l
2D:4D tertile G (95% CI) P2trend r3 P4 G (95% CI) P2trend r3 P4 G (95% CI) P2trend r3 P4
Testosterone (nmol/l) I 15.9 (15.3 - 16.4) 0.04 -0.05 0.12 15.6 (15.0 - 16.2) 0.34 -0.03 0.34 15.5 (14.9 - 16.0) 0.86 -0.02 0.44
II 15.3 (14.8 - 15.9) 15.3 (14.7 - 15.8) 15.3 (14.7 - 15.8)
III 15.0 (14.5 - 15.6) 15.2 (14.7 - 15.8) 15.4 (14.9 - 16.0)
Free testosterone (pmol/l) I 242.1 (232.1 - 252.0) 0.07 -0.04 0.19 237.4 (227.7 - 247.2) 0.50 -0.02 0.51 236.6 (226.8 - 246.4) 0.81 -0.03 0.42
II 233.5 (224.0 - 243.0) 232.8 (223.3 - 242.3) 232.8 (223.2 - 242.4)
III 229.1 (219.7 - 238.6) 232.7 (223.1 - 242.3) 234.9 (225.2 - 244.6)
Oestradiol (pmol/l) I 104.3 (99.6 - 108.9) 0.73 0.02 0.45 104.5 (99.8 - 109.2) 0.83 0.02 0.41 104.4 (99.8 - 109.1) 0.84 -0.00 0.96
II 105.6 (100.9 - 110.3) 105.3 (100.6 - 109.9) 105.7 (101.0 - 110.5)
III 105.0 (100.3 - 109.7) 104.9 (100.3 - 109.6) 104.9 (100.2 - 109.6)
Free oestradiol (pmol/l) I 1.7 (1.6 - 1.8) 0.51 0.03 0.31 1.7 (1.6 - 1.8) 0.58 0.03 0.26 1.7 (1.6 - 1.8) 0.92 -0.00 0.99
II 1.7 (1.7 - 1.8) 1.7 (1.6 - 1.8) 1.7 (1.7 - 1.8)
III 1.7 (1.6 - 1.8) 1.7 (1.6 - 1.8) 1.7 (1.6 - 1.8)
DHEAS (μmol/l) I 3.3 (3.1 - 3.5) 0.37 -0.03 0.28 3.4 (3.2 - 3.6) 0.07 -0.04 0.13 3.3 (3.1 - 3.5) 0.68 0.01 0.64
II 3.4 (3.2 - 3.6) 3.2 (3.0 - 3.4) 3.2 (3.0 - 3.4)
III 3.2 (3.0 - 3.4) 3.2 (3.0 - 3.3) 3.4 (3.2 - 3.6)
Androstenedione (nmol/l) I 4.2 (3.9 - 4.4) 0.30 -0.05 0.12 4.2 (4.0 - 4.4) 0.31 -0.04 0.26 4.2 (4.0 - 4.4) 0.96 -0.02 0.52
II 4.2 (3.9 - 4.4) 4.2 (3.9 - 4.4) 4.0 (3.8 - 4.2)
III 4.0 (3.8 - 4.2) 4.0 (3.8 - 4.2) 4.2 (4.0 - 4.4)
Androstenediol glucoronide (ng/ml) I 13.9 (13.0 - 14.8) 0.11 0.05 0.11 14.0 (13.2 - 14.9) 0.32 0.03 0.32 14.2 (13.3 - 15.1) 0.49 0.02 0.57
II 14.3 (13.4 - 15.2) 14.4 (13.5 - 15.3) 14.2 (13.4 - 15.1)
III 14.8 (13.9 - 15.7) 14.6 (13.7 - 15.5) 14.6 (13.7 - 15.5)
SHHB (nmol/l) I 35.0 (33.6 - 36.3) 0.50 -0.02 0.57 34.7 (33.4 - 36.0) 0.60 -0.02 0.60 34.5 (33.2 - 35.8) 0.98 -0.01 0.82
II 33.9 (32.6 - 35.2) 34.0 (32.8 - 35.3) 34.0 (32.7 - 35.3)
III 34.3 (33.0 - 35.6) 34.2 (33.0 - 35.5) 34.5 (33.2 - 35.8)
1Estimates from linear mixed models of the logarithm of hormone concentration on 2D:4D tertiles with laboratory batch entered as a random intercept, adjusted for ethnicity, age at blood draw, BMI, and smoking
status.
2From likelihood ratio test for linear trend across 2D:4D tertiles.
3Standardised regression coefficients (correlations) from linear mixed models of the logarithm of hormone concentration on continuous 2D:4D with laboratory batch entered as a random intercept, adjusted for
ethnicity, age at blood draw, BMI, and smoking status.
4From likelihood ratio test of r.
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Table 4 Predicted geometric mean (G1) hormone concentration in women by tertiles of right and left 2D:4D and Δr-l.
Right Hand Left Hand Δr-l
2D:4D tertile G (95% CI) P2trend r3 P4 G (95% CI) P2trend r3 P4 G (95% CI) P2trend r3 P4
Testosterone (nmol/L) I 0.7 (0.6 - 0.8) 0.76 -0.01 0.74 0.7 (0.6 - 0.8) 0.10 -0.03 0.41 0.6 (0.5 - 0.7) 0.04 0.02 0.55
II 0.7 (0.6 - 0.7) 0.7 (0.6 - 0.7) 0.7 (0.6 - 0.8)
III 0.7 (0.6 - 0.7) 0.6 (0.5 - 0.7) 0.7 (0.6 - 0.8)
Free Testosterone (pmol/L) I 6.0 (4.9 - 7.1) 0.92 -0.03 0.49 6.5 (5.3 - 7.6) 0.16 -0.04 0.34 5.2 (4.3 - 6.1) 0.05 0.02 0.71
II 6.6 (5.4 - 7.8) 6.4 (5.3 - 7.6) 6.9 (5.6 - 8.1)
III 5.9 (4.9 - 7.0) 5.6 (4.6 - 6.5) 6.5 (5.3 - 7.6)
Oestradiol (pmol/L) I 57.0 (52.1 - 61.9) 0.50 0.02 0.63 58.0 (52.9 - 63.0) 0.77 0.02 0.64 55.1 (50.3 - 59.9) 0.62 -0.00 0.91
II 55.6 (50.8 - 60.3) 55.3 (50.5 - 60.1) 59.7 (54.5 - 64.8)
III 58.7 (53.7 - 63.7) 57.2 (52.2 - 62.2) 56.4 (51.5 - 61.3)
Free oestradiol (pmol/L) I 0.8 (0.7 - 0.9) 0.85 -0.00 0.89 0.8 (0.7 - 0.9) 0.64 0.00 0.95 0.8 (0.7 - 0.8) 0.73 -0.01 0.73
II 0.8 (0.7 - 0.8) 0.8 (0.7 - 0.8) 0.8 (0.7 - 0.9)
III 0.8 (0.7 - 0.9) 0.8 (0.7 - 0.9) 0.8 (0.7 - 0.8)
DHEAS (μmol/L) I 1.5 (1.3 - 1.6) 0.38 -0.02 0.63 1.6 (1.4 - 1.7) 0.08 -0.02 0.62 1.4 (1.2 - 1.5) 0.44 0.00 0.91
II 1.4 (1.3 - 1.6) 1.4 (1.3 - 1.5) 1.4 (1.3 - 1.6)
III 1.4 (1.2 - 1.5) 1.4 (1.2 - 1.5) 1.5 (1.3 - 1.6)
Androstenedione (nmol/L) I 2.4 (2.2 - 2.6) 0.26 -0.04 0.40 2.4 (2.2 - 2.7) 0.16 -0.05 0.27 2.2 (2.0 - 2.4) 0.10 0.01 0.77
II 2.3 (2.1 - 2.5) 2.3 (2.1 - 2.5) 2.3 (2.1 - 2.5)
III 2.2 (2.1 - 2.4) 2.3 (2.1 - 2.4) 2.4 (2.2 - 2.6)
Oestrone sulphate (ng/mL) I 1.1 (1.0 - 1.2) 0.68 -0.03 0.44 1.1 (1.0 - 1.2) 0.35 -0.01 0.85 1.0 (0.9 - 1.1) 0.51 -0.01 0.72
II 1.0 (0.9 - 1.1) 1.0 (0.9 - 1.1) 1.0 (0.9 - 1.1)
III 1.0 (1.0 - 1.1) 1.0 (0.9 - 1.1) 1.1 (1.0 - 1.1)
SHGB (nmol/L) I 48.3 (45.3 - 51.3) 0.26 0.06 0.13 49.5 (46.4 - 52.6) 0.74 0.04 0.26 50.0 (46.8 - 53.1) 0.65 0.02 0.66
II 50.8 (47.7 - 54.0) 50.0 (46.9 - 53.0) 48.6 (45.6 - 51.6)
III 50.6 (47.5 - 53.8) 50.2 (47.1 - 53.3) 50.9 (47.8 - 54.1)
1Estimates from linear mixed models of the logarithm of hormone concentration on 2D:4D tertiles with laboratory batch entered as a random intercept, adjusted
for ethnicity, age at blood draw, BMI, smoking status, previous oral contraceptive and HRT use, parity, duration of lactation, and age at menarche.
2From likelihood ratio test for linear trend across 2D:4D tertiles.
3Standardised regression coefficients (correlations) from linear mixed models of the logarithm of hormone concentration on continuous 2D:4D with laboratory
batch entered as a random intercept, adjusted for ethnicity, age at blood draw, BMI, smoking status, previous oral contraceptive and HRT use, parity, duration of
lactation, and age at menarche.
4From likelihood ratio test of r.
Table 5 Predicted mean1 relative concentrations of testosterone and oestradiol in men by tertiles of right and left
2D:4D and Δr-l.
Right Hand Left Hand Δr-l
2D:4D tertile mean (95% CI) P2trend r3 P4 mean (95% CI) P2trend r3 P4 mean (95% CI) P2trend r3 P4
Testosterone:
oestradiol
I 160.2 (152.6 - 167.9) 0.03 -0.06 0.03 158.9 (151.3 - 166.5) 0.19 -0.05 0.07 155.7 (148.1 - 163.4) 0.82 -0.01 0.69
II 154.1 (146.5 - 161.8) 153.4 (145.9 - 160.9) 154.0 (146.4 - 161.7)
III 152.1 (144.5 - 159.8) 154.2 (146.6 - 161.7) 156.5 (148.9 - 164.2)
Free
testosterone:
free
oestradiol
I 157.0 (148.6 - 165.4) 0.02 -0.07 0.02 155.4 (147.1 - 163.8) 0.11 -0.06 0.04 151.1 (142.6 - 159.5) 0.92 -0.01 0.64
II 148.5 (140.1 - 156.9) 147.4 (139.0 - 155.7) 148.3 (139.9 - 156.8)
III 146.2 (137.8 - 154.6) 148.1 (139.7 - 156.4) 151.5 (143.0 - 160.0)
1Estimates from linear mixed models of the ratio of hormone concentrations on 2D:4D tertiles with laboratory batch entered as a random intercept, adjusted for
ethnicity, age at blood draw, BMI, and smoking status.
2From likelihood ratio test for linear trend across 2D:4D tertiles.
3Standardised regression coefficients (correlations) from linear mixed models of the logarithm of hormone concentration on continuous 2D:4D with laboratory
batch entered as a random intercept, adjusted for ethnicity, age at blood draw, BMI, and smoking status.
4From likelihood ratio test of r.
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Table 6 Predicted mean1 relative concentrations of testosterone and oestradiol in women by tertiles of right and left 2D:4D and Δr-l.
Right Hand Left Hand Δr-l
2D:4D tertile mean (95% CI) P2trend r3 P4 mean (95% CI) P2trend r3 P4 mean (95% CI) P2trend r3 P4
Testosterone:oestradiol I 15.0 (13.0 - 16.9) 0.39 -0.03 0.38 14.6 (12.6 - 16.5) 0.56 -0.03 0.52 14.0 (12.1 - 16.0) 0.24 -0.00 0.98
II 14.7 (12.8 - 16.6) 15.4 (13.4 - 17.3) 14.6 (12.6 - 16.5)
III 14.2 (12.3 - 16.1) 14.0 (12.1 - 16.0) 15.1 (13.2 - 17.1)
Free testosterone:free oestradiol I 11.4 (9.6 - 13.3) 0.58 -0.04 0.32 11.2 (9.4 - 13.0) 0.68 -0.02 0.60 10.7 (8.8 - 12.5) 0.31 -0.01 0.83
II 11.6 (9.7 - 13.4) 11.9 (10.1 - 13.7) 11.4 (9.6 - 13.3)
III 10.9 (9.1 - 12.7) 10.8 (9.0 - 12.6) 11.7 (9.8 - 13.5)
1Estimates from linear mixed models of the ratio of hormone concentrations on 2D:4D tertiles with laboratory batch entered as a random intercept, adjusted for ethnicity, age at blood draw, BMI, smoking status,
previous oral contraceptive and HRT use, parity, duration of lactation, and age at menarche.
2From likelihood ratio test for linear trend across 2D:4D tertiles.
3Standardised regression coefficients (correlations) from linear mixed models of the logarithm of hormone concentration on continuous 2D:4D with laboratory batch entered as a random intercept, adjusted for
ethnicity, age at blood draw, BMI, smoking status, previous oral contraceptive and HRT use, parity, duration of lactation, and age at menarche.
4From likelihood ratio test of r.
M
uller
et
al.Reproductive
Biology
and
Endocrinology
2011,9:57
http://w
w
w
.rbej.com
/content/9/1/57
Page
10
of
12
interpreted directly, independent of any effects of adult
circulating sex hormones.
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